Researcher

Srinivasaraghavan Kannan is a Principal Scientist at the Bioinformatics Institute (BII) and is an expert in the computational modelling of biomolecules. He has successfully developed and applied computational methods for the design and development of proteins, peptides and small molecular inhibitors. He collaborates closely with several academic groups, clinicians and biotech and pharmaceutical companies worldwide in his work. He holds eight patents on stapled peptides and small molecule inhibitors; one of them is out-licensed to SiNOPSEE Therapeutics that was spun out of A*STAR, of which he is a co-founder together with three A*STAR colleagues. He is also the co-founder of a startup, Aplomex, with another colleague from A*STAR.